CA Stock MarketDetailed Quotes

NAV Navco Pharmaceuticals Inc

Watchlist

0.025
0.0000.00%

15min DelayMarket Closed Nov 15 16:00 ET

1.43MMarket Cap-1250P/E (TTM)

Navco Pharmaceuticals Inc Key Stats

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Mar 31, 2023

(Q2)Dec 31, 2022

(FY)Sep 30, 2022

(Q1)Sep 30, 2022

(Q4)Jun 30, 2022

(Q3)Mar 31, 2022

(Q2)Dec 31, 2021

(Q1)Sep 30, 2021

(FY)Jun 30, 2021

(Q4)Jun 30, 2021

Assets

Current assets

Cash, cash equivalents and short term investments

--0

-96.92%104

-87.28%1.54K

82.41%21.54K

-85.09%1.8K

-96.06%2.21K

-94.10%3.38K

-82.93%11.81K

-93.34%12.07K

-Cash and cash equivalents

--0

-96.92%104

-87.28%1.54K

82.41%21.54K

-85.09%1.8K

-96.06%2.21K

-94.10%3.38K

-82.93%11.81K

-93.34%12.07K

Receivables

-12.87%94.75K

-12.83%93.4K

-46.26%55.87K

-12.78%92.05K

6.17%110.37K

6.17%108.74K

6.17%107.14K

6.17%105.54K

--103.96K

-Loans receivable

-12.87%94.75K

-12.83%93.4K

----

-12.78%92.05K

6.17%110.37K

6.17%108.74K

6.17%107.14K

6.17%105.54K

--103.96K

-Taxes receivable

----

--55.87K

----

Inventory

----

--3.02K

----

Total current assets

-14.60%94.75K

-15.40%93.5K

-47.92%60.42K

-3.20%113.59K

-3.32%112.17K

-29.95%110.94K

-31.41%110.52K

-30.40%117.35K

-35.99%116.03K

Non current assets

Net PPE

----

--219.24K

----

-Gross PPE

----

--286.81K

----

-Accumulated depreciation

----

---67.58K

----

Goodwill and other intangible assets

----

--45.2K

----

-Other intangible assets

----

--45.2K

----

Total non current assets

--0

--264.44K

--0

Total assets

-14.60%94.75K

-15.40%93.5K

179.98%324.86K

-3.20%113.59K

-3.32%112.17K

-29.95%110.94K

-31.41%110.52K

-30.40%117.35K

-35.99%116.03K

Liabilities

Current liabilities

Current debt and capital lease obligation

--155

----

--166K

----

-Current debt

--155

----

--154.72K

----

-Current capital lease obligation

----

--11.29K

----

Payables

50.62%90.51K

74.81%66.72K

7,508.31%810.67K

131.36%64.03K

468.44%60.57K

104.33%60.09K

156.96%38.16K

264.40%27.68K

-21.32%10.66K

-accounts payable

50.62%90.51K

74.81%66.72K

1,496.83%170.14K

131.36%64.03K

468.44%60.57K

104.33%60.09K

156.96%38.16K

264.40%27.68K

-21.32%10.66K

-Due to related parties current

----

--628.18K

----

-Other payable

----

--12.34K

----

Current accrued expenses

--210

120.58%31.22K

294.87%32.46K

640.49%48.13K

485.55%48.13K

--0

--14.15K

0.00%6.5K

26.46%8.22K

Current liabilities

51.23%90.87K

87.19%97.93K

5,246.36%1.01M

228.20%112.16K

475.89%108.7K

104.33%60.09K

252.26%52.32K

142.47%34.18K

-5.83%18.88K

Non current liabilities

Long term debt and capital lease obligation

----

--103.84K

----

-Long term capital lease obligation

----

--103.84K

----

Total non current liabilities

--0

--103.84K

--0

Total liabilities

51.23%90.87K

87.19%97.93K

5,796.50%1.11M

228.20%112.16K

475.89%108.7K

104.33%60.09K

252.26%52.32K

142.47%34.18K

-5.83%18.88K

Shareholders'equity

Share capital

0.00%315.85K

177.55%876.63K

0.00%315.85K

-0.00%315.85K

7.34%315.85K

-common stock

0.00%315.85K

177.55%876.63K

0.00%315.85K

-0.00%315.85K

7.34%315.85K

Retained earnings

-13.24%-401.7K

-18.03%-410.01K

-439.76%-1.66M

-25.36%-404.15K

-30.37%-402.1K

-28.25%-354.72K

-33.97%-347.37K

-33.74%-322.4K

-31.61%-308.42K

Other equity interest

0.00%89.73K

----

0.00%89.73K

-11.45%89.73K

Total stockholders'equity

-92.38%3.87K

-107.61%-4.43K

-911.21%-788.11K

-98.28%1.43K

-96.43%3.47K

-60.57%50.85K

-60.21%58.21K

-46.17%83.17K

-39.74%97.15K

Total equity

-92.38%3.87K

-107.61%-4.43K

-911.21%-788.11K

-98.28%1.43K

-96.43%3.47K

-60.57%50.85K

-60.21%58.21K

-46.17%83.17K

-39.74%97.15K

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Mar 31, 2023	(Q2)Dec 31, 2022	(FY)Sep 30, 2022	(Q1)Sep 30, 2022	(Q4)Jun 30, 2022	(Q3)Mar 31, 2022	(Q2)Dec 31, 2021	(Q1)Sep 30, 2021	(FY)Jun 30, 2021	(Q4)Jun 30, 2021
Assets
Current assets
Cash, cash equivalents and short term investments	--0	-96.92%104	-87.28%1.54K	82.41%21.54K	-85.09%1.8K	-96.06%2.21K	-94.10%3.38K	-82.93%11.81K	-93.34%12.07K	-93.34%12.07K
-Cash and cash equivalents	--0	-96.92%104	-87.28%1.54K	82.41%21.54K	-85.09%1.8K	-96.06%2.21K	-94.10%3.38K	-82.93%11.81K	-93.34%12.07K	-93.34%12.07K
Receivables	-12.87%94.75K	-12.83%93.4K	-46.26%55.87K	-12.78%92.05K	6.17%110.37K	6.17%108.74K	6.17%107.14K	6.17%105.54K	--103.96K	--103.96K
-Loans receivable	-12.87%94.75K	-12.83%93.4K	----	-12.78%92.05K	6.17%110.37K	6.17%108.74K	6.17%107.14K	6.17%105.54K	--103.96K	--103.96K
-Taxes receivable	----	----	--55.87K	----	----	----	----	----	----	----
Inventory	----	----	--3.02K	----	----	----	----	----	----	----
Total current assets	-14.60%94.75K	-15.40%93.5K	-47.92%60.42K	-3.20%113.59K	-3.32%112.17K	-29.95%110.94K	-31.41%110.52K	-30.40%117.35K	-35.99%116.03K	-35.99%116.03K
Non current assets
Net PPE	----	----	--219.24K	----	----	----	----	----	----	----
-Gross PPE	----	----	--286.81K	----	----	----	----	----	----	----
-Accumulated depreciation	----	----	---67.58K	----	----	----	----	----	----	----
Goodwill and other intangible assets	----	----	--45.2K	----	----	----	----	----	----	----
-Other intangible assets	----	----	--45.2K	----	----	----	----	----	----	----
Total non current assets	--0	--0	--264.44K	--0	--0	--0	--0	--0	--0	--0
Total assets	-14.60%94.75K	-15.40%93.5K	179.98%324.86K	-3.20%113.59K	-3.32%112.17K	-29.95%110.94K	-31.41%110.52K	-30.40%117.35K	-35.99%116.03K	-35.99%116.03K
Liabilities
Current liabilities
Current debt and capital lease obligation	--155	----	--166K	----	----	----	----	----	----	----
-Current debt	--155	----	--154.72K	----	----	----	----	----	----	----
-Current capital lease obligation	----	----	--11.29K	----	----	----	----	----	----	----
Payables	50.62%90.51K	74.81%66.72K	7,508.31%810.67K	131.36%64.03K	468.44%60.57K	104.33%60.09K	156.96%38.16K	264.40%27.68K	-21.32%10.66K	-21.32%10.66K
-accounts payable	50.62%90.51K	74.81%66.72K	1,496.83%170.14K	131.36%64.03K	468.44%60.57K	104.33%60.09K	156.96%38.16K	264.40%27.68K	-21.32%10.66K	-21.32%10.66K
-Due to related parties current	----	----	--628.18K	----	----	----	----	----	----	----
-Other payable	----	----	--12.34K	----	----	----	----	----	----	----
Current accrued expenses	--210	120.58%31.22K	294.87%32.46K	640.49%48.13K	485.55%48.13K	--0	--14.15K	0.00%6.5K	26.46%8.22K	26.46%8.22K
Current liabilities	51.23%90.87K	87.19%97.93K	5,246.36%1.01M	228.20%112.16K	475.89%108.7K	104.33%60.09K	252.26%52.32K	142.47%34.18K	-5.83%18.88K	-5.83%18.88K
Non current liabilities
Long term debt and capital lease obligation	----	----	--103.84K	----	----	----	----	----	----	----
-Long term capital lease obligation	----	----	--103.84K	----	----	----	----	----	----	----
Total non current liabilities	--0	--0	--103.84K	--0	--0	--0	--0	--0	--0	--0
Total liabilities	51.23%90.87K	87.19%97.93K	5,796.50%1.11M	228.20%112.16K	475.89%108.7K	104.33%60.09K	252.26%52.32K	142.47%34.18K	-5.83%18.88K	-5.83%18.88K
Shareholders'equity
Share capital	0.00%315.85K	0.00%315.85K	177.55%876.63K	0.00%315.85K	0.00%315.85K	-0.00%315.85K	-0.00%315.85K	7.34%315.85K	7.34%315.85K	7.34%315.85K
-common stock	0.00%315.85K	0.00%315.85K	177.55%876.63K	0.00%315.85K	0.00%315.85K	-0.00%315.85K	-0.00%315.85K	7.34%315.85K	7.34%315.85K	7.34%315.85K
Retained earnings	-13.24%-401.7K	-18.03%-410.01K	-439.76%-1.66M	-25.36%-404.15K	-30.37%-402.1K	-28.25%-354.72K	-33.97%-347.37K	-33.74%-322.4K	-31.61%-308.42K	-31.61%-308.42K
Other equity interest	0.00%89.73K	0.00%89.73K	----	0.00%89.73K	0.00%89.73K	0.00%89.73K	0.00%89.73K	-11.45%89.73K	-11.45%89.73K	-11.45%89.73K
Total stockholders'equity	-92.38%3.87K	-107.61%-4.43K	-911.21%-788.11K	-98.28%1.43K	-96.43%3.47K	-60.57%50.85K	-60.21%58.21K	-46.17%83.17K	-39.74%97.15K	-39.74%97.15K
Total equity	-92.38%3.87K	-107.61%-4.43K	-911.21%-788.11K	-98.28%1.43K	-96.43%3.47K	-60.57%50.85K	-60.21%58.21K	-46.17%83.17K	-39.74%97.15K	-39.74%97.15K
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

NAV Navco Pharmaceuticals Inc

Navco Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow